NEW YORK ( TheStreet) -- CHANGE IN RATINGSAO Smith ( AOS) rated new Market Perform at BMO. $55 price target. Company is seeing slower domestic growth. Brookfield Infrastructure Partners ( BIP) rated new Neutral at Citigroup. $34 price target. Fully valued at current levels despite risk averse business model. Centerpoint ( CNP) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $21 price target. CIFC ( DFR) downgraded to sell at TheStreet Ratings. Facebook ( FB) rated new Hold at Argus. Still uncertain how the company will monetize growth in mobile access. Intercontinental Exchange ( ICE) rated new Hold at BGB Securities. $145 price target. Lower commodity prices and volatility could weigh on volumes. Laboratory Corp. of America ( LH) rated new Buy at Canaccord. $100 price target. Company is a low-cost provider and volumes have likely troughed. NII ( NIHD) downgraded at Wells to Market Perform, Wells Fargo said. Estimates also cut, as the dollar remains an earnings headwind. New Mountain Finance ( NMFC) initiated as hold at TheStreet Ratings. Onyx Pharmaceuticals ( ONXX) rated new Buy at Deutsche. $58 price target. Kyprolis should be the company's next main growth driver. Onyx Pharmaceuticals upgraded at Brean Murray from Hold to Buy. $60 price target. New cancer drug should be approved by the FDA next month. TJX Companies ( TJX) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Company is likely gaining market share from JCP, which could help boost sales growth. Under Armour ( UA) downgraded at UBS to Neutral from Buy, UBS said. $105 price target. Stock run, high valuation, diminishing outperformance. Woodward ( WWD) rated new Outperform at Credit Suisse. $48 price target. Company has strong market positioning and can deliver consistent organic growth. Wright Express ( WXS) downgraded at Citigroup to Sell from Neutral, Citigroup said. $56 price target. Near term pressures from declining fuel prices.
STOCK COMMENTS / EPS CHANGES
Accenture ( ACN) estimates, target cut at BMO. Shares of ACN now seen reaching $66, according to BMO Capital. Estimates also reduced, given currency headwinds. Market Perform rating. Bed, Bath & Beyond ( BBBY) estimates cut at Credit Suisse through 2014, Credit Suisse said. Comp sales have slowed down. Outperform rating and $91 price target.